EP2622088 - MANNOSIDASES CAPABLE OF UNCAPPING MANNOSE-1-PHOSPHO-6-MANNOSE LINKAGES AND DEMANNOSYLATING PHOSPHORYLATED N-GLYCANS AND METHODS OF FACILITATING MAMMALIAN CELLULAR UPTAKE OF GLYCOPROTEINS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 28.07.2017 Database last updated on 30.10.2024 | Most recent event Tooltip | 23.02.2024 | Change - applicant | published on 27.03.2024 [2024/13] | Applicant(s) | For all designated states Oxyrane UK Limited 83 Ducie Street Manchester M1 2JQ / GB | [2024/13] |
Former [2014/47] | For all designated states Oxyrane UK Limited Suite 313, Piccadilly House 49 Piccadilly Manchester M1 2AP / GB | ||
Former [2013/32] | For all designated states Oxyrane UK Limited Greenheys House Manchester Science Park 10 Pencroft Way Manchester M15 6JJ / GB | Inventor(s) | 01 /
NOELLA, Gwenda, Pynaert Riethulstraat 7 B-9880 Aalter / BE | 02 /
PIENS, Kathleen Camilla, Telesphore Alida Maria Citadellaan 54 B-9000 Gent / BE | 03 /
VALEVSKA, Albena, Vergilieva Maaltebruggestraat 197 B-9000 Gent / BE | 04 /
VERVECKEN, Wouter Edmond Van Hoorebekestraat 90 B-9050 Gent-ledeberg / BE | [2013/32] | Representative(s) | Michalík, Andrej, et al De Clercq & Partners cvba Edgard Gevaertdreef 10 a 9830 Sint-Martens-Latem / BE | [2014/36] |
Former [2013/32] | White, Martin Paul Whites IP Ltd 7 Berwick Road Bournemouth BH3 7BB / GB | Application number, filing date | 11796810.7 | 29.09.2011 | WO2011IB02770 | Priority number, date | US201161477014P | 19.04.2011 Original published format: US 201161477014 P | US20100387940P | 29.09.2010 Original published format: US 387940 P | [2013/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012042386 | Date: | 05.04.2012 | Language: | EN | [2012/14] | Type: | A2 Application without search report | No.: | EP2622088 | Date: | 07.08.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.04.2012 takes the place of the publication of the European patent application. | [2013/32] | Search report(s) | International search report - published on: | EP | 31.05.2012 | Classification | IPC: | C12P19/26, C12P21/00, A61K38/43, C12N9/10, C12N15/81 | [2013/32] | CPC: |
C12P21/005 (EP,US);
C12P19/26 (KR);
A61K38/16 (EP,US);
A61K38/1709 (EP,US);
A61K38/43 (KR);
A61P43/00 (EP);
C12N9/10 (KR);
C12N9/2402 (EP,US);
C12N9/2488 (EP,US);
C12P21/00 (KR);
C12Y302/01024 (EP,US);
A61K38/00 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/32] | Title | German: | MANNOSIDASEN ZUM ENTKAPPEN VON MANNOSE-1-PHOSPHO-6-MANNOSE-BINDUNGEN UND DEMANNOSYLIERUNG VON PHOSPHORYLIERTEN N-GLYKANEN SOWIE VERFAHREN ZUR ERMÖGLICHUNG DER ZELLULÄREN AUFNAHME VON GLYKOPROTEINEN DURCH SÄUGERZELLEN | [2013/32] | English: | MANNOSIDASES CAPABLE OF UNCAPPING MANNOSE-1-PHOSPHO-6-MANNOSE LINKAGES AND DEMANNOSYLATING PHOSPHORYLATED N-GLYCANS AND METHODS OF FACILITATING MAMMALIAN CELLULAR UPTAKE OF GLYCOPROTEINS | [2013/32] | French: | MANNOSIDASES CAPABLES D'ÉLIMINER LA COIFFE DES LIAISONS MANNOSE-1-PHOSPHO- 6-MANNOSE ET DE DÉMANNOSYLER LES N-GLYCANES PHOSPHORYLÉS, ET MÉTHODES FACILITANT L'ASSIMILATION DES GLYCOPROTÉINES PAR DES CELLULES DE MAMMIFÈRES | [2013/32] | Entry into regional phase | 26.04.2013 | National basic fee paid | 26.04.2013 | Designation fee(s) paid | 26.04.2013 | Examination fee paid | Examination procedure | 30.07.2012 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 26.04.2013 | Examination requested [2013/32] | 29.11.2013 | Amendment by applicant (claims and/or description) | 27.07.2017 | Despatch of a communication from the examining division (Time limit: M06) | 30.01.2018 | Reply to a communication from the examining division | 22.05.2019 | Despatch of a communication from the examining division (Time limit: M06) | 26.11.2019 | Reply to a communication from the examining division | 17.03.2021 | Despatch of a communication from the examining division (Time limit: M06) | 22.09.2021 | Reply to a communication from the examining division | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.07.2017 | Fees paid | Renewal fee | 27.09.2013 | Renewal fee patent year 03 | 01.08.2014 | Renewal fee patent year 04 | 25.09.2015 | Renewal fee patent year 05 | 22.09.2016 | Renewal fee patent year 06 | 26.09.2017 | Renewal fee patent year 07 | 25.09.2018 | Renewal fee patent year 08 | 24.09.2019 | Renewal fee patent year 09 | 24.09.2020 | Renewal fee patent year 10 | 22.09.2021 | Renewal fee patent year 11 | 27.09.2022 | Renewal fee patent year 12 | 26.09.2023 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]EP1408117 (NAT INST OF ADVANCED IND SCIEN [JP], et al) [X] 1-4,6-8,15,22,23,29,31-33,35-52 * page 4, paragraph [0021] - page 9, paragraph [0027] * * page 12, paragraphs [0051]-[0052]; examples 1,2,4,6 * [Y] 3-5,9-14,16-21,24-28,30,34; | [XY]WO2004074498 (HAMILTON STEPHEN R [US], et al) [X] 1,2,43-48,57,58 * page 10, paragraph [0021] - page 11, paragraph [0023] * * page 12, paragraph [0025] - page 13, paragraph [0028] * * page 17, paragraph [0040] - page 22, paragraph [0066] * * page 45, paragraph [0162] - page 54, paragraph [186] * * page 91, paragraph [568] - page 94, paragraph [577] * * page 118, paragraph [0635] - page 120, paragraph [637]; table 6 * * examples 1,2,6,8,9,17-23 * [Y] 3,9,11,16,18,20,24,27; | [XY]WO2008120107 (OXYRANE UK LTD [GB], et al) [X] 43-58 * page 1, line 19 - page 2, line 7 * * page 2, line 19 - page 3, line 30 * * page 4, lines 7-27 * * page 5, lines 15-18 * * page 7, lines 19-24 * * page 26, line 20 - page 28, line 15 * * page 37, line 26 - page 38, line 3; examples 2-4,11-13,15-16 * [Y] 3-5,9-14,16-21,24-28,30,34; | [XP]WO2011039634 (UNIV GENT [BE], et al) [XP] 1-58* the whole document *; | [XY] - CHIBA YASUNORI ET AL, "Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, (20021201), vol. 12, no. 12, doi:10.1093/GLYCOB/CWF096, ISSN 0959-6658, pages 821 - 828, XP002509578 [X] 1,2,4,6-8,15,22,23,29,31-33,35-52 * abstract * * page 821, column r, paragraph l - page 826, column l, paragraph 1 * [Y] 3-5,9-14,16-21,24-28,30,34 DOI: http://dx.doi.org/10.1093/glycob/cwf096 | [Y] - MERKLE R K ET AL, "Cloning, expression, purification, and characterization of the murine lysosomal acid alpha-mannosidase", BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, (19970827), vol. 1336, no. 2, doi:10.1016/S0304-4165(97)00023-8, ISSN 0304-4165, pages 132 - 146, XP004276600 [Y] 3-5,9-14,16-21,24-28,30,34 * abstract * * page 132, column r, paragraph 1 - page 133, column r, paragraph 2 * * page 142, column l, paragraph 2 - page 143, column r, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0304-4165(97)00023-8 | [Y] - VANDERSALL-NAIRN AS ET AL, "Cloning, expression, purification, and characterization of the acid alpha-mannosidase from Trypanosoma cruzi", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, (19981201), vol. 8, no. 12, doi:10.1093/GLYCOB/8.12.1183, ISSN 0959-6658, pages 1183 - 1194, XP002628928 [Y] 3-5,9-14,16-21,24-28,30,34 * page 1183, column l, paragraph l - column r, paragraph 3 * * page 1186, column l, paragraph l - page 1187, column r, paragraph 2 * DOI: http://dx.doi.org/10.1093/glycob/8.12.1183 | [Y] - LIAO Y-F ET AL, "CLONING, EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF THE HUMAN BROAD SPECIFICITY LYSOSOMAL ACID ALPHA-MANNOSIDASE", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC, US, (19961108), vol. 271, no. 45, doi:10.1074/JBC.271.20.11838, ISSN 0021-9258, pages 28348 - 28358, XP001118202 [Y] 3-5,9-14,16-21,24-28,30,34 * abstract * * page 28353, column r, paragraph l - page 28354, column r, paragraph 1 * DOI: http://dx.doi.org/10.1074/jbc.271.20.11838 | [Y] - GONZALEZ DANIEL S ET AL, "The alpha-mannosidases: Phylogeny and adaptive diversification", MOLECULAR BIOLOGY AND EVOLUTION, THE UNIVERSITY OF CHICAGO PRESS, US, (20000201), vol. 17, no. 2, ISSN 0737-4038, pages 292 - 300, XP002293609 [Y] 3-5,9-14,16-21,24-28,30,34 * page 293, column r, paragraph 2 * * page 294, column r, paragraph 2 - page 296, column r, paragraph 1; figures 1,2 * | [Y] - MARTINET W ET AL, "Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase", EUROPEAN JOURNAL OF BIOCHEMISTRY 1997 DE, (1997), vol. 247, no. 1, ISSN 0014-2956, pages 332 - 338, XP002671071 [Y] 3,4,9,11,16,18,20,24,27 * abstract * * page 333, column r, paragraph 3 * * page 335, column l, paragraph l * DOI: http://dx.doi.org/10.1111/j.1432-1033.1997.00332.x | Examination | - Anonymous, "CAZy - GH38", (20190516), pages 1 - 5, URL: http://www.cazy.org/GH38_characterized.html, (20190516), XP055589554 | - ICHISHIMA EIJI ET AL, "Molecular and enzymic properties of recombinant 1,2-alpha-mannosidase from Aspergillus saitoi overexpressed in Aspergillus oryzae cells", 19990501, (19990501), vol. 339, no. 3, pages 589 - 597, XP002353325 | by applicant | US4307717 | US4352883 | US4353888 | US4407957 | US4704362 | US4837148 | US4879231 | US4882279 | US4883666 | US4929555 | US4968733 | US4976859 | US5084350 | US5158881 | WO9219195 | US5284761 | WO9505452 | US5798113 | US5800828 | US6265185 | US2006014264 | WO2011039634 | - Current Protocols in Molecular Biology, JOHN WILEY & SONS, (1991), pages 6.3.1 - 6.3.6 | - HOWARD ET AL., J. BIOL. CHEM., (1998), vol. 273, no. 4, pages 2067 - 2072 | - BURTON; HARDING, J. CHROMATOGR. A, (1998), vol. 814, pages 71 - 81 | - MOREAU ET AL., J. BIOL. CHEM., (1991), vol. 266, no. 7, pages 4329 - 4333 | - MOREAU ET AL., J. BIOL. CHEM., (1991), vol. 266, no. 7, pages 4322 - 4328 | - REXACH ET AL., J. CELL BIOL., (1991), vol. 114, no. 2, pages 219 - 229 | - PAULIK ET AL., ARCH. BIOCHEM. BIOPHYS., (1999), vol. 367, no. 2, pages 265 - 273 | - HENDERSON; FINN, ADVANCES IN IMMUNOLOGY, (1996), vol. 62, pages 217 - 256 | - NEWMAN; FERRO-NOVICK, J. CELL BIOL., (1987), vol. 105, no. 4, page 1587 | - GUARENTE ET AL., PROC. NATL. ACAD. SCI. USA, (1982), vol. 79, no. 23, page 7410 | - ZHU; ZHANG, BIOINFORMATICS, (1999), vol. 15, no. 7-8, pages 608 - 611 | - GOSSEN ET AL., ANN. REV. GENETICS, (2002), vol. 3 6, pages 153 - 173 | - HINNEN ET AL., PROC. NAT. ACAD. SCI. USA, (1978), vol. 75, page 1929 | - ITO ET AL., J. BACTERIOL., (1983), vol. 153, page 163 | - SREEKRISHNA ET AL., GENE, (1987), vol. 59, page 115 | - CREGG; RUSSEL, Methods in Molecular Biology: Pichia Protocols, HUMANA PRESS, (1998), pages 27 - 39 | - CALLEWAERT ET AL., GLYCOBIOLOGY, (2001), vol. 11, no. 4, pages 275 - 281 | - FREIRE ET AL., BIOCONJUG. CHEM., (2006), vol. 17, no. 2, pages 559 - 564 | - Remington's Pharmaceutical Sciences, MAACK PUBLISHING CO. | - ANNALS OF PHARMACOTHERAPY, (1993), vol. 27, page 912 | - CANCER, (1993), vol. 41, page 1270 | - CANCER RESEARCH, (1984), vol. 44, page 1698 | - LAROY ET AL., NATURE PROTOCOLS, (2006), vol. 1, pages 397 - 405 |